Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant - Priority Announcement: Pediatric Cancer Research

Université Laval

$100,000.00

Clinical significance and natural history of clinically unsuspected central venous catheter-related thrombosis in children with cancer

EF 2022-23

Résumé
Blood clots are a known complication of cancer and its treatment. In children, blood clots are often linked to a central venous line, a device inserted in the body to deliver medicine, fluids, or nutrients. While some blood clots can lead to serious short- and long-term complications, it is unknown whether all clots are equally important. It is questioned whether unsuspected blood clots (otherwise called incidental) may lead to such complications. Understanding which blood clots are dangerous is important so healthcare practitioners can tailor the treatment using a patient-centered approach. Children at high risk of complications could benefit from medicine to treat adequately blood clots and minimize their impact. Conversely, in children at low risk of complications, the adverse effects (mostly bleeding), costs and burden of such medicine could be spared. To address this question, we will perform a study enrolling children with cancer requiring a central venous line. We will determine whether they have an incidental clot using a painless test called a Doppler ultrasound. As this exam is not done as part of routine care, the results will not be communicated to the healthcare team. Children will then be followed for six months to detect any short-term complications of blood clots, including clot progression, infection, or dysfunction of the central venous line. We will follow the children for two years to determine whether they develop post-thrombotic syndrome, the most common complication of symptomatic blood clots. We will compare whether complications were more frequent among children who developed incidental clots, compared to those who did not. We will also explore potential risk factors for blood clots among children with cancer to identify markers present in children at high risk of blood clots. As survival from childhood cancer has increased drastically in the past decades, it is increasingly important to prevent complications and late effects of treatment.
Programme
Project Grant - Priority Announcement: Pediatric Cancer Research
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
473370
Name
Pelland-Marcotte Marie-Claude
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Clinical
Prcname2
Clinical Investigation - A: Reproduction, Maternal, Child and Youth Health
Projecttitle
Clinical significance and natural history of clinically unsuspected central venous catheter-related thrombosis in children with cancer
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - Priority Announcement: Pediatric Cancer Research
Keyworddelim
Biomarkers; Central Venous Catheters; Children; Thrombosis
Abstract
Blood clots are a known complication of cancer and its treatment. In children, blood clots are often linked to a central venous line, a device inserted in the body to deliver medicine, fluids, or nutrients. While some blood clots can lead to serious short- and long-term complications, it is unknown whether all clots are equally important. It is questioned whether unsuspected blood clots (otherwise called incidental) may lead to such complications. Understanding which blood clots are dangerous is important so healthcare practitioners can tailor the treatment using a patient-centered approach. Children at high risk of complications could benefit from medicine to treat adequately blood clots and minimize their impact. Conversely, in children at low risk of complications, the adverse effects (mostly bleeding), costs and burden of such medicine could be spared. To address this question, we will perform a study enrolling children with cancer requiring a central venous line. We will determine whether they have an incidental clot using a painless test called a Doppler ultrasound. As this exam is not done as part of routine care, the results will not be communicated to the healthcare team. Children will then be followed for six months to detect any short-term complications of blood clots, including clot progression, infection, or dysfunction of the central venous line. We will follow the children for two years to determine whether they develop post-thrombotic syndrome, the most common complication of symptomatic blood clots. We will compare whether complications were more frequent among children who developed incidental clots, compared to those who did not. We will also explore potential risk factors for blood clots among children with cancer to identify markers present in children at high risk of blood clots. As survival from childhood cancer has increased drastically in the past decades, it is increasingly important to prevent complications and late effects of treatment.
Competitiondate
202209
Approvedterm2
1 yr 0 mth
Pinamesdelim
Pelland-Marcotte, Marie-Claude
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~